These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8050490)

  • 1. Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential.
    Huang A; Jin H; Wright JA
    Exp Cell Res; 1994 Aug; 213(2):335-9. PubMed ID: 8050490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G; Funghini S; Witort E; Magnelli L; Fanti E; Rifkin DB; Del Rosso M
    J Cell Physiol; 2002 Oct; 193(1):64-72. PubMed ID: 12209881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
    Huang A; Jin H; Wright JA
    Cancer Res; 1995 Apr; 55(8):1758-62. PubMed ID: 7712485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein alterations associated with gene amplification in cultured human and rodent cells.
    Conner EA; Wirth PJ
    Electrophoresis; 1996 Jul; 17(7):1257-64. PubMed ID: 8855414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
    Taylor WR; Greenberg AH; Turley EA; Wright JA
    Exp Cell Res; 1993 Feb; 204(2):295-301. PubMed ID: 8440326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome rearrangements associated with CAD gene amplification. Experiments with cell hybrids.
    Viaggi S; Nüsse M; Ottaggio L; Bonatti S
    Mutat Res; 1992 Jan; 265(1):9-21. PubMed ID: 1370246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
    El-Hizawi S; Lagowski JP; Kulesz-Martin M; Albor A
    Cancer Res; 2002 Jun; 62(11):3264-70. PubMed ID: 12036943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based model for tumor drug resistance.
    Kuczek T; Chan TC
    Cancer Chemother Pharmacol; 1992; 30(5):355-9. PubMed ID: 1505073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole.
    Tessera L; Mucciolo E; Bertoni L; Giulotto E
    Anticancer Res; 1995; 15(1):189-92. PubMed ID: 7733632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms.
    Bikfalvi A; Klein S; Pintucci G; Quarto N; Mignatti P; Rifkin DB
    J Cell Biol; 1995 Apr; 129(1):233-43. PubMed ID: 7698988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New RNA species is produced by alternate polyadenylation following rearrangement associated with CAD gene amplification.
    Meinkoth JL; Legouy E; Brison O; Wahl GM
    Somat Cell Mol Genet; 1986 Jul; 12(4):339-50. PubMed ID: 2426798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
    Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
    Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct chromosomal alterations associated with TP53 status of LoVo cells under PALA selective pressure: a parallel with cytogenetic pathways of colorectal cancers.
    Soulie P; Poupon MF; Remvikos Y; Dutrillaux B; Muleris M
    Oncogene; 1999 Jan; 18(3):775-81. PubMed ID: 9989828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.
    Paulson TG; Almasan A; Brody LL; Wahl GM
    Mol Cell Biol; 1998 May; 18(5):3089-100. PubMed ID: 9566927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of K-FGF or bFGF results in altered expression of matrix metalloproteinases: correlations with malignant progression and cellular invasion.
    Lo J; Hurta RA
    Cell Biol Int; 2002; 26(4):319-25. PubMed ID: 11991661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of the novel joints present in the amplified DNA of N-phosphonacetyl-L-aspartate resistant Drosophila cells: implication on the mechanisms of amplification in these cells.
    Azou Y; Laval M
    Biol Cell; 1993; 77(2):155-64. PubMed ID: 8364394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.